D'Incalci M - Search Results

1

Corrections to "Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors".

Soria JC, DeBraud F, Bahleda R, Adamo B, Andre F, Dienstmann R, Delmonte A, Cereda R, Isaacson J, Litten J, Allen A, Dubois F, Saba C, Robert R, D'Incalci M, Zucchetti M, Camboni MG, Tabernero J. Soria JC, et al. Ann Oncol. 2015 Feb;26(2):445. doi: 10.1093/annonc/mdu547. Epub 2020 Jan 7. Ann Oncol. 2015. PMID: 32590894 Free article. No abstract available.

2

Activity of aphidicolin glycinate alone or in combination with cisplatin in a murine ovarian tumor resistant to cisplatin.

Damia G, Tagliabue G, Zucchetti M, Davoli E, Sessa C, Cavalli F, D'Incalci M. Damia G, et al. Cancer Chemother Pharmacol. 1992;30(6):459-64. doi: 10.1007/BF00685597. Cancer Chemother Pharmacol. 1992. PMID: 1394802

3

Do anticancer agents reach the tumor target in the human brain?

Donelli MG, Zucchetti M, D'Incalci M. Donelli MG, et al. Cancer Chemother Pharmacol. 1992;30(4):251-60. doi: 10.1007/BF00686291. Cancer Chemother Pharmacol. 1992. PMID: 1643692 Review.

4

Concentrations of VP16 and VM26 in human brain tumors.

Zucchetti M, Rossi C, Knerich R, Donelli MG, Butti G, Silvani V, Gaetani P, D'Incalci M. Zucchetti M, et al. Ann Oncol. 1991 Jan;2(1):63-6. doi: 10.1093/oxfordjournals.annonc.a057826. Ann Oncol. 1991. PMID: 2009235 Free article.

5

Pharmacokinetics of intrapleural versus intravenous etoposide (VP 16) and teniposide (VM 26) in patients with malignant pleural effusion.

Montaldo PG, Figoli F, Zanette ML, Sorio R, Zucchetti M, Tirelli U, D'Incalci M. Montaldo PG, et al. Oncology. 1990;47(1):55-61. doi: 10.1159/000226785. Oncology. 1990. PMID: 2300386

6

Pharmacokinetics of 4-demethoxydaunorubicin in cancer patients.

Zanette L, Zucchetti M, Freshi A, Erranti D, Tirelli U, D'Incalci M. Zanette L, et al. Cancer Chemother Pharmacol. 1990;25(6):445-8. doi: 10.1007/BF00686057. Cancer Chemother Pharmacol. 1990. PMID: 2311174

7

A gas chromatographic mass spectrometric assay for the determination of aphidicolin in plasma of cancer patients.

Rotondo S, Zucchetti M, Sessa C, D'Incalci M, Benfenati E, Fanelli R. Rotondo S, et al. J Pharm Sci. 1989 May;78(5):399-401. doi: 10.1002/jps.2600780511. J Pharm Sci. 1989. PMID: 2501472

8

Temozolomide induced differentiation of K562 leukemia cells is not mediated by gene hypomethylation.

Zucchetti M, Catapano CV, Filippeschi S, Erba E, D'Incalci M. Zucchetti M, et al. Biochem Pharmacol. 1989 Jul 1;38(13):2069-75. doi: 10.1016/0006-2952(89)90059-2. Biochem Pharmacol. 1989. PMID: 2660797

9

Identification of microsomal metabolites of spirogermanium.

Benfenati E, Zucchetti M, D'Incalci M. Benfenati E, et al. Anticancer Res. 1989 Mar-Apr;9(2):507-10. Anticancer Res. 1989. PMID: 2751274

10

Phase I study of the antifolate N10-propargyl-5,8-dideazafolic acid, CB 3717.

Sessa C, Zucchetti M, Ginier M, Willems Y, D'Incalci M, Cavalli F. Sessa C, et al. Eur J Cancer Clin Oncol. 1988 Apr;24(4):769-75. doi: 10.1016/0277-5379(88)90313-6. Eur J Cancer Clin Oncol. 1988. PMID: 3383977

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

564 results

Search Page

Filters